Literature DB >> 27021055

Is the evidence base of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder flawed?

Pieter J Hoekstra1, Jan K Buitelaar2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27021055     DOI： 10.1007/s00787-016-0845-2

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN： 1018-8827            Impact factor:   4.785


× No keyword cloud information.
  4 in total

1.  Five-fold increase in national prevalence rates of attention-deficit/hyperactivity disorder medications for children and adolescents with autism spectrum disorder, attention-deficit/hyperactivity disorder, and other psychiatric disorders: a Danish register-based study.

Authors:  Søren Dalsgaard; Helena Skyt Nielsen; Marianne Simonsen
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-09-09       Impact factor: 2.576

2.  Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003-2011.

Authors:  Susanna N Visser; Melissa L Danielson; Rebecca H Bitsko; Joseph R Holbrook; Michael D Kogan; Reem M Ghandour; Ruth Perou; Stephen J Blumberg
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-11-21       Impact factor: 8.829

3.  Age-specific prevalence, incidence of new diagnoses, and drug treatment of attention-deficit/hyperactivity disorder in Germany.

Authors:  Christina Lindemann; Ingo Langner; Angela A Kraut; Tobias Banaschewski; Tanja Schad-Hansjosten; Ulrike Petermann; Franz Petermann; Ina Schreyer-Mehlhop; Edeltraut Garbe; Rafael T Mikolajczyk
Journal:  J Child Adolesc Psychopharmacol       Date:  2012-08-02       Impact factor: 2.576

Review 4.  Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

Authors:  Ole Jakob Storebø; Erica Ramstad; Helle B Krogh; Trine Danvad Nilausen; Maria Skoog; Mathilde Holmskov; Susanne Rosendal; Camilla Groth; Frederik L Magnusson; Carlos R Moreira-Maia; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Bente Forsbøl; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2015-11-25
  4 in total
  9 in total

1.  The evidence base of methylphenidate for children and adolescents with attention-deficit hyperactivity disorder is in fact flawed.

Authors:  Ole Jakob Storebø; Erik Simonsen; Christian Gluud
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-04-30       Impact factor: 4.785

2.  Response to: The evidence base of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder is in fact flawed.

Authors:  Pieter J Hoekstra; Jan K Buitelaar
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-09       Impact factor: 4.785

3.  Towards a better understanding of the many facets of attention-deficit/hyperactivity disorder.

Authors:  Pieter J Hoekstra
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-03       Impact factor: 4.785

Review 4.  Attention-Deficit/Hyperactivity Disorder.

Authors:  Tobias Banaschewski; Katja Becker; Manfred Döpfner; Martin Holtmann; Michael Rösler; Marcel Romanos
Journal:  Dtsch Arztebl Int       Date:  2017-03-03       Impact factor: 5.594

5.  Clinical factors associated with decision to recommend methylphenidate treatment for children with ADHD in France.

Authors:  Elodie Courtabessis; Florence Pupier; Laurie Surig; Marie-Christine Picot; Erika Nogué; Valérie Macioce; Elizabeth Stein; Diane Purper-Ouakil
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-10-05       Impact factor: 4.785

Review 6.  Treatment strategies for ADHD: an evidence-based guide to select optimal treatment.

Authors:  Arthur Caye; James M Swanson; David Coghill; Luis Augusto Rohde
Journal:  Mol Psychiatry       Date:  2018-06-28       Impact factor: 15.992

Review 7.  What do general practitioners know about ADHD? Attitudes and knowledge among first-contact gatekeepers: systematic narrative review.

Authors:  Mimi Tatlow-Golden; Lucia Prihodova; Blanaid Gavin; Walter Cullen; Fiona McNicholas
Journal:  BMC Fam Pract       Date:  2016-09-07       Impact factor: 2.497

8.  The Cochrane Collaboration withdraws a review on methylphenidate for adults with attention deficit hyperactivity disorder.

Authors:  Kim Boesen; Luis Carlos Saiz; Juan Erviti; Ole Jakob Storebø; Christian Gluud; Peter C Gøtzsche; Karsten Juhl Jørgensen
Journal:  Evid Based Med       Date:  2017-07-13

9.  Prevalence and comorbidity of attention deficit hyperactivity disorder in Spain: study protocol for extending a systematic review with updated meta-analysis of observational studies.

Authors:  Ferrán Catalá-López; Manuel Ridao; Amparo Núñez-Beltrán; Ricard Gènova-Maleras; Adolfo Alonso-Arroyo; Rafael Aleixandre-Benavent; Miguel A Catalá; Rafael Tabarés-Seisdedos
Journal:  Syst Rev       Date:  2019-02-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.